The mammalian immune system has developed surveillance mechanisms that can detect cancerous cells. However successful tumor cells have evolved strategies to evade detection. Current therapeutic strategies focus on improving cancer cell recognition and tumor elimination. Both immunocompetent and immunodeficient mouse models have been instrumental in the development of these therapies.
In this webinar you will learn about:
Registration is Open
We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.